Parabens inhibit hNa V 1.2 channels
Propylparaben, a commonly used antimicrobial preservative, has been reported as an anticonvulsant agent targeting neuronal Na channels (Na ). However, the specific features of the Na channel inhibition by this agent have so far not been extensively studied. Moreover, it is still unclear if it shares...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2020-08, Vol.128, p.110250 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Propylparaben, a commonly used antimicrobial preservative, has been reported as an anticonvulsant agent targeting neuronal Na
channels (Na
). However, the specific features of the Na
channel inhibition by this agent have so far not been extensively studied. Moreover, it is still unclear if it shares this pharmacological activity with other parabens. Here, we fully characterized the mechanism of action of the inhibitory effect that propylparaben and benzylparaben induce on human Na
1.2 channel isoform (hNa
1.2). We established a first approach to know the parabens structural determinants for this channel inhibition. The parabens effects on hNa
1.2 channel mediated currents were recorded using the patch-clamp whole-cell configuration on hNa
1.2 stably transfected HEK293 cells. Propylparaben induced a typical state-dependent inhibition on hNa
1.2 channel carried current, characterized by a left-shift in the steady-state inactivation curve, a prolongation in the time needed for recovery from fast inactivation and a frequency-dependent blocking behavior. The state-dependent inhibition is increased for butylparaben and benzylparaben and diminished for methylparaben, ethylparaben and p-hydroxybenzoic acid (the major metabolite of parabens hydrolysis). Particularly, butylparaben and benzylparaben shift the steady-state inactivation curve 2- and 3-times more than propylparaben, respectively. Parabens are blockers of hNa
1.2 channels, sharing the mechanism of action of most of sodium channel blocking antiseizure drugs. The potency of this inhibition increases with the size of the lipophilic alcoholic residue of the ester group. These results provide a basis for rational drug design directed to generate new potential anticonvulsant agents. |
---|---|
ISSN: | 1950-6007 |